NextCure, Inc. (NXTC) stock
NXTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.70+0.02 (+0.30%)
Close on Nov 17, 2026Market cap $30.67MP/E –Yield 0.00%
NextCure operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
NextCure's operating cash flow for the twelve months ending Jun 30, 2026 was -$36.98M. For fiscal 2025 it was -$49.61M. The highest annual figure on record is $7.99M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$49.61M | – |
| FY2024 | Dec 31, 2024 | -$40.81M | – |
| FY2023 | Dec 31, 2023 | -$52.97M | – |
| FY2022 | Dec 31, 2022 | -$53.89M | – |
| FY2021 | Dec 31, 2021 | -$57.28M | – |
| FY2020 | Dec 31, 2020 | -$44.95M | – |
| FY2019 | Dec 31, 2019 | -$35.62M | -545.7% |
| FY2018 | Dec 31, 2018 | $7.99M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$9.72M | – |
| Q1 FY2026 | Mar 31, 2026 | -$13.36M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.64M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.27M | – |
| Q2 FY2025 | Jun 30, 2025 | -$22.71M | – |
| Q1 FY2025 | Mar 31, 2025 | -$12.99M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.97M | – |
| Q3 FY2024 | Sep 30, 2024 | -$11.45M | – |
| Q2 FY2024 | Jun 30, 2024 | -$9.78M | – |
| Q1 FY2024 | Mar 31, 2024 | -$12.61M | – |
| Q4 FY2023 | Dec 31, 2023 | -$10.67M | – |
| Q3 FY2023 | Sep 30, 2023 | -$12.78M | – |
| Q2 FY2023 | Jun 30, 2023 | -$14.75M | – |
| Q1 FY2023 | Mar 31, 2023 | -$14.78M | – |
| Q4 FY2022 | Dec 31, 2022 | -$8.95M | – |
| Q3 FY2022 | Sep 30, 2022 | -$15.00M | – |
| Q2 FY2022 | Jun 30, 2022 | -$14.49M | – |
| Q1 FY2022 | Mar 31, 2022 | -$15.45M | – |
| Q4 FY2021 | Dec 31, 2021 | -$13.49M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.66M | – |
| Q2 FY2021 | Jun 30, 2021 | -$17.22M | – |
| Q1 FY2021 | Mar 31, 2021 | -$13.91M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.28M | – |
| Q3 FY2020 | Sep 30, 2020 | -$15.67M | – |
| Q2 FY2020 | Jun 30, 2020 | -$12.41M | – |
| Q1 FY2020 | Mar 31, 2020 | -$10.59M | – |
| Q4 FY2019 | Dec 31, 2019 | -$9.99M | -144.5% |
| Q3 FY2019 | Sep 30, 2019 | -$7.95M | – |
| Q2 FY2019 | Jun 30, 2019 | -$10.61M | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.08M | – |
| Q4 FY2018 | Dec 31, 2018 | $22.47M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.72M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.96M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.80M | – |
See a number that looks wrong?